Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
A full-service, global contract research organization (CRO) has expanded its existing partnership with OmniComm Systems.
read more
Wednesday, April 15, 2020
Cytel has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration.
read more
The global clinical trial management market was valued at $570 million in 2016, and is estimated to reach $1,371 million by 2023, registering a CAGR of 13.4% from 2017 to 2023 according to a recently released report.
read more
According to a new report published by Allied Market Research, titled, "Antibody Drug Conjugates Market by Drugs, Mechanism of Action and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global antibody drug conjugates ...
read more
Wednesday, January 24, 2018
Cogstate has been chosen by the Global Alzheimer’s Platform Foundation to support GAP’s RCP that will increase the speed and quality of Alzheimer’s clinical trials.
read more
Tuesday, February 27, 2024
The artificial intelligence (AI) in drug discovery market is projected to reach USD 4.9 billion by 2028 from USD 900 million in 2023, at a CAGR of 40.2%
read more
Tuesday, February 19, 2019
Gliknik announced that it will receive a $15 million milestone payment from Pfizer following the start of a Phase I clinical trial of Pfizer drug candidate PF-06755347, previously known as GL-2045.
read more
Glenmark Pharmaceuticals and Harbour BioMed have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 1302.
read more
Monday, December 23, 2019
Glenmark Pharmaceutical announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to the consumer level.
read more
Glenmark Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) cleared the Company's Investigational New Drug (IND) application to begin a Phase 2 study of GSP 304 (tiotropium bromide) for administration by nebulization for ...
read more
Thursday, February 07, 2019
Perrigo has received final approval from the FDA for its AB rated Abbreviated NDA referencing Zovirax Cream, 5% (acyclovir cream, 5%) developed in collaboration with Sol-Gel Technologies.
read more
Glenmark Pharmaceuticals has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma.
read more
Glenmark Pharmaceuticals announced its subsidiary Glenmark Specialty has entered into an exclusive licensing agreement with Seqirus to commercialize Ryaltris in Australia and New Zealand.
read more
Glen Research has achieved ISO 9001:2015 certification.
read more
Arria NLG announced a collaboration with Glemser Technologies to bring scalable automation solutions and major efficiencies to healthcare and pharmaceuticals companies.
read more